Skip to main content

Advertisement

SpringerLink
Log in

Topiramate for migraine prevention

  • Clinical Trials Report
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lipton RB, Stewart WF, Diamond S, et al.: Prevalence and burden of migraine in the United States: data from the American migraine II study. Headache 2001, 41:646–657.

    Article  PubMed  CAS  Google Scholar 

  2. Silberstein SD: Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review); report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 55:754–762.

    PubMed  CAS  Google Scholar 

  3. Silberstein SD, Neto W, Schmitt J, et al.: Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol 2004, 61:490–495.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Jerry W. Swanson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Swanson, J.W. Topiramate for migraine prevention. Curr Neurol Neurosci Rep 5, 77–78 (2005). https://doi.org/10.1007/s11910-005-0002-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-005-0002-7

Keywords

Search

Navigation